08:00
Circulation, Volume 150, Issue 1, Page 47-48, July 2, 2024. (Circulation)
08:00
Circulation, Volume 150, Issue 1, Page 1-3, July 2, 2024. (Circulation)
08:00
Circulation, Volume 150, Issue 1, Page 80-81, July 2, 2024. (Circulation)
08:00Effect of Apixaban on Clinical Outcomes in Outpatients With COVID-19: The APOLLO Randomized Clinical Trial -
Pedro Gabriel Melo de Barros e Silva Ariane Vieira Scarlatelli Macedo Bruna Bronhara Lucas Petri Damiani Lilian Mazza Barbosa Nathália Rodrigues Lopes Mayra Akimi Suiama Murillo O. Antunes Mariana Raquel Gonçalves Otávio Celso Eluf Gebara Priscilla de Aquino Martins Mariana Galvão Ribeiro João Batista de Moura Xavier de Moraes Valéria Cristina Resende Aguiar Alexandre B. Cavalcanti Regis G. Rosa Otavio Berwanger Viviane C. Veiga Luciano C.P. Azevedo Eduardo Ramacciotti Christopher B. Granger John H. Alexander Alvaro Avezum Renato D. Lopes Brazilian Clinical Research Institute, São Paulo, (…)
Circulation
Circulation, Volume 150, Issue 1, Page 82-85, July 2, 2024. (Circulation)
08:00
Circulation, Volume 150, Issue 1, Page e1-e2, July 2, 2024. (Circulation)
08:00
Circulation, Volume 150, Issue 1, Page 4-6, July 2, 2024. (Circulation)
08:00
Circulation, Volume 150, Issue 1, Page e3-e4, July 2, 2024. (Circulation)
08:00Response by Berry et al to Letter Regarding Article, “Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial” -
Colin Berry Novalia P. Sidik Margaret B. McEntegart West of Scotland Heart and Lung Centre, National Health Service Golden Jubilee, Glasgow, United Kingdom (C.B., N.P.S., M.B.M.). British Heart Foundation Glasgow Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, United Kingdom (C.B., N.P.S., M.B.M.). Department of Cardiology, Columbia University Medical Center, New York, New York (M.B.M.).
Circulation
Circulation, Volume 150, Issue 1, Page e5-e6, July 2, 2024. (Circulation)
08:00
Circulation, Volume 150, Issue 1, Page 62-79, July 2, 2024. Despite data suggesting that apolipoprotein B (apoB) measurement outperforms low-density lipoprotein cholesterol level measurement in predicting atherosclerotic cardiovascular disease risk, apoB measurement has not become widely adopted (…) (Circulation)